China’s pharma industry is best known for being the low-cost generic API producer to the world. But companies there, large and small, are looking for ways to move up the value chain, including doing ...
Some FDA warning letters are long, drawn-out documents listing specific and multiple violations and sometimes offering a blueprint for fixing issues. Others are short and to the point, essentially ...
With the increasing competitiveness of China's pharmaceutical industry, Chinese pharmaceutical products are making rapid strides in the global arena, spurring China to become the world's largest ...
Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's pharma sector despite temporary inventory buffers ...
China, the world leader in the API industry, is on a consolidation path and quality drive to raise its own benchmarks in the global turf, that too with no qualms about the tightening quality norms ...
A German manufacturer of OTC products and a Chinese supplier of active pharmaceutical ingredients (APIs) were told to adopt better equipment cleaning practices in recent warning letters from the US ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Illustration shows OpenAI logo BEIJING (Reuters) -Chinese artificial intelligence (AI) companies are moving swiftly to ...
BEIJING (Reuters) -Chinese artificial intelligence (AI) companies are moving swiftly to attract users of OpenAI's technology, following reports the U.S. firm plans to restrict access in China and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results